Literature DB >> 35685694

Effects of Yunnan Baiyao on the Differentiation of HPDLFs on the Bio-Oss® Collagen Scaffold in vivo.

Xiaohong Yu1, Jing Wang1, Qianqian Han1, Wen Chu1, Shaowen Lu1, Yu Liu2, Yi Peng1, Jie Xu1, Yanqing Shui1.   

Abstract

Background: Yunnan Baiyao, as a traditional Chinese herbal remedy with definite curative effect, has recently been proven can promote the proliferation of osteoblasts and differentiation of human periodontal ligament fibroblasts. Bio-Oss® scaffold is a porous bone graft material of natural and antigen-free bovine bone origin.
Methods: To observe the effect of Yunnan Baiyao on the differentiation of HPDLFs on the Bio-Oss® collagen scaffold in vivo, the HPDLFs-Bio-Oss® collagen complex was constructed in vitro, and Yunnan Baiyao aqueous solution was added, respectively. The complex was divided into Yunnan Baiyao group I (50 μg/mL), Yunnan Baiyao group II (100 μg/mL), positive control (rhBMP-2) group and sham group. HPDLFs were identified by immunocytochemistry and immunofluorescence. The compatibility of HPDLFs with Bio-Oss® collagen was observed by fluorescence microscope and scanning electron microscope. The specimens were taken for HE staining after 8 weeks since the complex was implanted into nude mice, and the expressions of osteocalcin (OC), bone sialoprotein (BSP), osteopontin (OPN), and collagen I (CON-I) were detected by immunohistochemistry and qRT-PCR.
Results: The number of capillaries and osteoblasts increased significantly after Yunnan Baiyao stimulation, and the expressions of BSP, OC, OPN and CON-I were increased after Yunnan Baiyao stimulation in a dose-dependent manner.
Conclusion: Yunnan Baiyao solution can promote the differentiation of HPDLFs and the generation of capillaries on Bio-Oss® collagen scaffold in a dose-dependent manner.
© 2022 Yu et al.

Entities:  

Keywords:  Bio-Oss® collagen; Yunnan Baiyao; differentiation; human periodontal ligament fibroblasts

Year:  2022        PMID: 35685694      PMCID: PMC9173728          DOI: 10.2147/IJGM.S359921

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  42 in total

1.  An old herbal medicine with a potentially new therapeutic application in inflammatory bowel disease.

Authors:  Richard Li; Philip Alex; Mei Ye; Ting Zhang; Ling Liu; Xuhang Li
Journal:  Int J Clin Exp Med       Date:  2011-10-29

2.  Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins.

Authors:  G K Hunter; P V Hauschka; A R Poole; L C Rosenberg; H A Goldberg
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

3.  Effect of interleukin-1β on bone morphogenetic protein-9-induced osteoblastic differentiation of human periodontal ligament fibroblasts.

Authors:  Yukari Ebe; Toshiaki Nakamura; Kozue Hasegawa-Nakamura; Kazuyuki Noguchi
Journal:  Eur J Oral Sci       Date:  2021-05-04       Impact factor: 2.612

4.  Expression of BSP-GFPtpz Transgene during Osteogenesis and Reparative Dentinogenesis.

Authors:  A Vijaykumar; P Dyrkacz; I Vidovic-Zdrilic; P Maye; M Mina
Journal:  J Dent Res       Date:  2019-11-04       Impact factor: 6.116

5.  NIK inhibitor impairs chronic periodontitis via suppressing non-canonical NF-κB and osteoclastogenesis.

Authors:  Jiang Wang; Bo Wang; Xin Lv; Lei Wang
Journal:  Pathog Dis       Date:  2020-10-07       Impact factor: 3.166

Review 6.  Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair.

Authors:  M D McKee; A Nanci
Journal:  Microsc Res Tech       Date:  1996-02-01       Impact factor: 2.769

7.  Absence of bone sialoprotein (BSP) impairs primary bone formation and resorption: the marrow ablation model under PTH challenge.

Authors:  Ndéye Marième Wade-Gueye; Maya Boudiffa; Arnaud Vanden-Bossche; Norbert Laroche; Jane E Aubin; Laurence Vico; Marie-Hélène Lafage-Proust; Luc Malaval
Journal:  Bone       Date:  2012-05       Impact factor: 4.398

8.  Hierarchical micro/nanofibrous membranes of sustained releasing VEGF for periosteal regeneration.

Authors:  Liang Wu; Yong Gu; Lili Liu; Jincheng Tang; Jiannan Mao; Kun Xi; Zhirong Jiang; Yidi Zhou; Yun Xu; Lianfu Deng; Liang Chen; Wenguo Cui
Journal:  Biomaterials       Date:  2019-10-18       Impact factor: 12.479

9.  Collagen type I induces EGFR-TKI resistance in EGFR-mutated cancer cells by mTOR activation through Akt-independent pathway.

Authors:  Shota Yamazaki; Youichi Higuchi; Masayuki Ishibashi; Hiroko Hashimoto; Masahiro Yasunaga; Yasuhiro Matsumura; Katsuya Tsuchihara; Masahiro Tsuboi; Koichi Goto; Atsushi Ochiai; Genichiro Ishii
Journal:  Cancer Sci       Date:  2018-06       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.